Preferential blockade of postsynaptic alpha-adrenoceptors by BE 2254

Area of Science:

• Pharmacology
• Cardiovascular Research
• Adrenoceptor Studies

Background:

• Alpha-adrenoceptors play a crucial role in regulating cardiovascular function.
• Understanding the specific effects of novel compounds on these receptors is vital for drug development.

Purpose of the Study:

• To investigate the pre- and postsynaptic alpha-adrenoceptor effects of 2-[beta-(4-hydroxyphenyl)-ethyl-aminomethyl]-tetralone (BE 2254).

Main Methods:

• Isolated rabbit hearts and pulmonary artery strips were used.
• KCl-evoked noradrenaline output and clonidine inhibition were measured.
• Concentration-response curves for noradrenaline and electrically evoked tension were analyzed.

Main Results:

• BE 2254 increased endogenous noradrenaline output in rabbit hearts.
• It antagonized clonidine's inhibitory effect, indicating presynaptic alpha-adrenoceptor blockade.
• BE 2254 shifted noradrenaline concentration-response curves rightward in pulmonary arteries, suggesting postsynaptic blockade.

Conclusions:

• BE 2254 demonstrates a preference for blocking postsynaptic alpha-adrenoceptors.
• Despite affinity for presynaptic receptors, its primary action is postsynaptic blockade.